Petco Health and Wellness Stock (NASDAQ: WOOF)

Petco Health and Wellness Stock (NASDAQ:WOOF), Trade Ideas

Petco Health and Wellness

Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.

NYSE

Earnings

Equities

News

Futures

Previews

Economics

Federal Reserve

Pre-Market Outlook

Markets

Movers

$BTC

CALM

GOEV

PAYX

PLAY

TSLA

WOOF

U.S. stocks are expected to open lower on Tuesday, as worries from Monday’s session seem to carry over.

Wall Street Set For Weak Open As Fed Speeches, Key Data Eyed: Amid Bitcoin Plunge And Gold Spike, Market Analyst Sees &#39;Nothing Breaking The Upward Trend&#39;

Penny Stocks

Small Cap

Trading Ideas

BTBT

GCTS

GUTS

MSTR

U.S. stock futures were lower this morning, with the Dow futures falling by over 100 points on Tuesday.

PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday&#39;s Pre-Market Session

BETR

MLKN

RDDT

U.S. stock futures were mixed this morning, with the Dow futures gaining by around 10 points on Thursday.

MillerKnoll Posts Weak Sales, Joins Chemours, Rumble And Other Big Stocks Moving Lower In Thursday&#39;s Pre-Market Session

Petco Health and Wellness Company, Inc. - Class A Common Stock

Petco Health and Wellness Co Inc

WIIM

BURL

CHWY

CVNA

Shares of retail companies are trading lower amid overall market weakness on rate cut uncertainty.

CRMT

IRBT

LESL

RVLV

SNBR

Shares of retail companies are trading lower amid overall market weakness following hotter-than-expected March inflation data.

<h3>Gainers</h3>
<ul>
<li>Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) stock rose 6.4% to $19.85 during Wednesday's after-market session. The market value of their outstanding shares is at $7.9 billion. The company's, Q1 earnings came out today. </li>
<li>Selina Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares increased by 6.18% to $0.1. The market value of their outstanding shares is at $38.9 million. </li>
<li>Allbirds (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIRD#NASDAQ">BIRD</a>) stock moved upwards by 3.89% to $0.67. The company's market cap stands at $103.8 million. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) stock rose 3.64% to $0.23. The market value of their outstanding shares is at $3.3 million. </li>
<li>Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) shares rose 3.63% to $7.31. The market value of their outstanding shares is at $113.5 million. </li>
<li>Big Lots (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIG#NYSE">BIG</a>) stock increased by 3.29% to $4.08. The company's market cap stands at $119.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jiuzi Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) shares decreased by 13.4% to $1.29 during Wednesday's after-market session. The market value of their outstanding shares is at $151.8 million. </li>
<li>Foresight Autonomous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSX#NASDAQ">FRSX</a>) stock fell 5.01% to $1.14. The market value of their outstanding shares is at $17.4 million. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) stock fell 4.56% to $0.06. The company's market cap stands at $6.1 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) shares decreased by 4.54% to $1.53. The market value of their outstanding shares is at $14.8 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) shares fell 3.96% to $1.92. The market value of their outstanding shares is at $516.6 million. </li>
<li>Kidpik (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) stock fell 3.61% to $4.55. The market value of their outstanding shares is at $8.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIRD

EZGO

FRSX

JZXN

LEVI

RRGB

SLNA

TRNR

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

Throughout the last three months, 7 analysts have evaluated Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $2.74, a high estimate of $5.00, and a low estimate of $1.50. Observing a downward trend, the current average is 27.7% lower than the prior average price target of $3.79. 
<img src="https://www.benzinga.com/files/images/story/2024/1712080820_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Petco Health and Wellness by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elizabeth Suzuki</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$1.50</td>
<td>$5.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$2.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$2.70</td>
<td>$3.50</td>
</tr>
<tr>
<td>Oliver Wintermantel</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$3.00</td>
<td>$4.00</td>
</tr>
<tr>
<td>Justin Kleber</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Anna Andreeva</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Petco Health and Wellness. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Petco Health and Wellness compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Petco Health and Wellness's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Petco Health and Wellness's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WOOF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Petco Health and Wellness analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Petco Health and Wellness's Background</h2>
Petco Health and Wellness Co Inc offer pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
<h3>Petco Health and Wellness: Delving into Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Petco Health and Wellness faced challenges, resulting in a decline of approximately -0.47% in revenue growth as of 31 October, 2023. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -83.07%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Petco Health and Wellness's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -68.81%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Petco Health and Wellness's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -20.53%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a high debt-to-equity ratio of 2.54, Petco Health and Wellness faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Key Takeaways From Petco Health and Wellness Analyst Ratings

<h3>Gainers</h3>
<ul>
<li>Kidpik (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) stock rose 60.9% to $7.0 during Tuesday's pre-market session. The company's market cap stands at $13.3 million. </li>
<li>ATA Creativity Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) shares increased by 10.0% to $1.1. The company's market cap stands at $34.5 million. </li>
<li>Secoo Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SECO#NASDAQ">SECO</a>) stock increased by 7.6% to $0.41. The market value of their outstanding shares is at $2.8 million. </li>
<li>Selina Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares increased by 6.07% to $0.15. The company's market cap stands at $56.1 million. </li>
<li>SRIVARU Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) shares rose 5.97% to $0.22. The market value of their outstanding shares is at $7.1 million. </li>
<li>Visionary Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GV#NASDAQ">GV</a>) shares increased by 5.52% to $0.18. The company's market cap stands at $9.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Canoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) shares declined by 24.3% to $2.93 during Tuesday's pre-market session. The company's market cap stands at $166.8 million. The company's, Q4 earnings came out yesterday. </li>
<li>PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) stock declined by 22.48% to $108.33. The company's market cap stands at $6.4 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) shares declined by 8.67% to $1.9. The market value of their outstanding shares is at $511.0 million. </li>
<li>Kaixin Auto Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) shares decreased by 7.71% to $0.17. The market value of their outstanding shares is at $4.5 million. </li>
<li>FIGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) shares decreased by 5.98% to $4.56. The market value of their outstanding shares is at $774.7 million. </li>
<li>Lotus Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) stock declined by 5.54% to $6.48. The market value of their outstanding shares is at $4.3 billion. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AACG

FIGS

KXIN

SECO

SVMH

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

Petco Health and Wellness shares are trading lower after B of A Securities downgraded the stock from Buy to Underperform and lowered its price target from $5 to $1.50.

B of A Securities analyst Elizabeth Suzuki downgrades Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) from Buy to Underperform and lowers the price target from $5 to $1.5.

Downgrades

Price Target

B of A Securities Downgrades Petco Health and Wellness to Underperform, Lowers Price Target to $1.5

U.S. stocks are expected to open lower on Tuesday, as <a href="https://www.benzinga.com/news/earnings/24/04/38039376/investor-sentiment-improves-but-dow-falls-over-200-points" target="_blank" rel="noreferrer noopener">worries from Monday&#8217;s session</a> seem to carry over. Investors will be closely watching economic data, particularly job market figures, to assess the economy&#8217;s health. Strong economic data could raise concerns about the Federal Reserve maintaining interest rates or even raising them further, which would likely be negative for the stock market. Additionally, several Fed speeches scheduled for today might offer clues about the future of interest rates.
Cues From Previous Session
Strong manufacturing data released on Monday spooked investors, leading to a mixed close for the market. The Institute for Supply Management&#8217;s (ISM) manufacturing purchasing managers&#8217; index (PMI) unexpectedly grew and moved into expansion territory. This data pushed bond yields higher, with the 10-year note yield reaching an intraday high of 4.337% before settling at 4.318%. With the expectation of potential rate cuts diminishing, investors sold stocks in response.
Major indices initially opened higher but reversed course after the ISM data release. The Dow Jones Industrial Average (DJIA) and the S&amp;P 500 Index both dipped below the flatline in early trading and continued a steady decline into the afternoon. They then consolidated around these lower levels for the rest of the day.
The Nasdaq Composite, though lagging below the flatline in mid-day trading, managed to recover and close slightly positive. However, it remains below its recent highs on March 21st and 22nd.
Eight out of 11 S&amp;P sectors closed in the red, with interest-rate-sensitive real estate stocks suffering the most significant losses. Conversely, communication services stocks saw a sharp rise, while energy and IT sectors also attracted some buying interest.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.11%</td>
<td>16,396.83</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>-0.20%</td>
<td>5,243.77</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>-0.60%</td>
<td>39,566.85</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.02%</td>
<td>2,102.84</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Despite fears regarding stretched valuations of tech stocks, an economist suggests they have more room to run. &#8220;Tech's momentum has withered a bit, but I don&#8217;t believe this sector has seen its highs,&#8221; said Jeremy Siegel, Senior Economist to&nbsp;WisdomTree, said in his weekly commentary.
The Emeritus Professor of Finance at the Wharton School&nbsp;said this week will clarify whether the record run of the previous one was end-of-quarter positioning or not. &#8220;I see nothing breaking the upward trend in equities and I hope it broadens out,&#8221; he added.
Fund manager Louis Navellier underlined two offshoots of a stronger economy. &#8220;The tension remains between the strength of the economy putting upward pressure on earnings estimates, while at the same time making it more likely that the Fed will stay higher for longer&nbsp;to push towards their 2% inflation target,&#8221; the analyst said.
He expects the Fed to bow to political pressure from the incumbent to ease rates ahead of the election and to &#8220;deal with any reigniting of inflation after the election.&#8221;
Futures Today
 Futures Performance On Tuesday ( as of 7 a.m. EDT)
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.34%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.27%</td>
</tr>
<tr>
<td>Dow</td>
<td>-0.39%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.63%</td>
</tr>
</tbody>
</table>
</figure>
In <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noreferrer noopener">premarket</a>&nbsp;trading on Tuesday, the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) slipped 0.21% to $521.07,&nbsp;and the&nbsp;Invesco QQQ ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.27% to $443.77 according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Upcoming Economic Data:
The Commerce Department is scheduled to release factory goods orders data at 10 a.m. EDT. Economists, on average, expect a 1% month-over-month increase in factory goods orders for February, reversing the 3.6% decline in the previous month. Durable goods orders, which account for the bulk of factory goods, climbed 1.4% in February, the Commerce Department said in late March.
The Bureau of Labor Statistics will release the results of the February Job Openings and Labor Turnover Survey at 10 a.m. EDT. The consensus estimate calls for job openings of 8.8 million for the month, a tick down from 8.9 million in January.
Fed Governor Michelle Bowman is due to speak at 10:10 a.m. EDT, Cleveland Fed President Loretta Mester at 12:05 p.m. EDT, and San Francisco Fed President Mary Daly at 1:30 a.m. EDT.
See Also: <a href="https://www.benzinga.com/money/best-strategies-for-futures-trading">Best Strategies for Futures Trading</a>
Stocks In Focus:
<ul>
<li>PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) and lifestyle electric-vehicle manufacturer Canoo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) fell over 22.50% <a href="https://www.benzinga.com/premarket">in premarket trading</a> following their earnings releases.</li>
<li>Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>), Dave &amp; Buster&#8217;s Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>), and Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) are among the companies <a href="https://www.benzinga.com/calendars/earnings">due to release their quarterly earnings </a>Tuesday.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell over 1.50% ahead of the release of its first-quarter deliveries.</li>
<li>Health insurance stocks Humana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>), Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>), UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), and CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) all fell sharply in the premarket. The U.S. Centers for Medicare &amp; Medicaid Services announced that payments to Medicare Advantage programs, which serve those aged 65 and older, will rise by 3.7% on average in 2025, in line with the initial estimate published in January, Reuters reported. This set off worries concerning potential margin contraction for insurers.</li>
</ul>
Commodities, Bonds, and Global Equity Markets:
Crude oil futures rallied nearly 2% to $85.35 on Tuesday and Gold futures pushed toward another record, with the yellow metal trading up about 1% at $2,280.85 per ounce. The yield on the benchmark 10-year Treasury rose marginally to 4.349%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) plunged hard Tuesday and pulled back about 4.70% toward the $66,000 level.
In Asia, the major markets traded lackluster, tracking the somber mood on Wall Street, although the Hong Kong market played catch-up and advanced notably on Tuesday. The Taiwanese market also rallied strongly.
European stocks showed tentativeness and traded narrowly mixed as they reopened after the Boxing Day holiday. Sore manufacturing activity data out of the region served to keep sentiment subdued. On the other hand, German inflation data showed a letup in pricing pressure in March.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38031108/investors-eye-next-moves-after-stellar-quarter-for-s-p-500-option-demand-for-black-">Investors Eye Next Moves After Stellar Quarter For S&amp;P 500: Option Demand For &#8216;Black Swan Events&#8217; Rises</a>
Photo via Shutterstock

Wall Street Set For Weak Open As Fed Speeches, Key Data Eyed: Amid Bitcoin Plunge And Gold Spike, Market Analyst Sees 'Nothing Breaking The Upward Trend'

U.S. stock futures were lower this morning, with the Dow futures falling by over 100 points on Tuesday.
Shares of PVH Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pvh#NYSE">PVH</a>) fell sharply in today&rsquo;s pre-market trading after the company reported fourth-quarter <a href="https://www.benzinga.com/news/earnings/24/04/38034386/tommy-hilfiger-calvin-klein-parent-pvh-corp-reports-q4-results-stock-falls-on-soft-q1-guidance">financial results and issued guidance</a>.
PVH reported quarterly earnings of $3.72 per share which beat the analyst consensus estimate of $3.53 by 5.38% and is a 56.3% increase over earnings of $2.38 per share from the same period last year. Quarterly sales came in at $2.49 billion which beat the analyst consensus estimate of $2.42 billion by 2.89%, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company sees fiscal year 2024 earnings of between $10.75 and $11.00 per share, versus the $10.48 estimate. Revenue is projected to decrease between 6% and 7% compared to 2023.
PVH shares tumbled 23.4% to $107.00 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>Fractyl Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/guts#NASDAQ">GUTS</a>) shares dipped 13.7% to $6.43 in pre-market trading amid volatility after the company reported fourth-quarter financial results.</li>
<li>GCT Semiconductor Holding, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gcts#NASDAQ">GCTS</a>) shares declined 12.6% to $15.82 in pre-market trading after declining over 45% on Monday. GCT Semiconductor appointed Nelson C. Chan to Board of Directors.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/woof#NASDAQ">WOOF</a>) shares fell 11.1% to $1.85 in pre-market trading after declining around 9% on Monday.</li>
<li>Humana Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hum#NYSE">HUM</a>) shares fell 8.8% to $320.55 in pre-market trading after the Centers for Medicare &amp; Medicaid Services (CMS) finalized payment updates. The CMS announced Monday that it finalized the calendar year 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) programs that updates payment policies for these programs and ensures payment accuracy.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) shares declined 7.1% to $1,521.00 in pre-market trading amid a decline in Bitcoin.</li>
<li>Bit Digital, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btbt#NASDAQ">BTBT</a>) shares fell 5.4% to $2.61 in pre-market trading amid a decline in Bitcoin.</li>
<li>CVS Health Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvs#NYSE">CVS</a>) shares declined 5.2% to $75.41 in pre-market trading after the Centers for Medicare &amp; Medicaid Services (CMS) finalized payment updates.</li>
<li>Lotus Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lot#NASDAQ">LOT</a>) shares declined 4.7% to $6.54 in pre-market trading. Lotus Technology is expected to report its unaudited fourth quarter before the opening bell on April 8, 2024.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38039376/investor-sentiment-improves-but-dow-falls-over-200-points"> Investor Sentiment Improves, But Dow Falls Over 200 Points</a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Torrid Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) shares rose 15.8% to $5.65 during Thursday's after-market session. The company's market cap stands at $588.1 million. As per the press release, Q4 earnings came out today. </li>
<li>Selina Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) stock rose 7.38% to $0.16. The company's market cap stands at $60.5 million. </li>
<li>Golden Sun Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) stock increased by 4.98% to $0.51. The market value of their outstanding shares is at $9.6 million. </li>
<li>Arcimoto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUV#NASDAQ">FUV</a>) shares increased by 3.44% to $0.48. The market value of their outstanding shares is at $4.5 million. </li>
<li>Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) stock rose 3.23% to $0.59. The market value of their outstanding shares is at $14.2 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) shares increased by 3.22% to $1.28. The market value of their outstanding shares is at $329.6 million. As per the press release, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Oxford Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) shares fell 7.0% to $104.5 during Thursday's after-market session. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q4 earnings came out today. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) shares fell 6.68% to $0.06. The company's market cap stands at $6.2 million. </li>
<li>Faraday Future (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares fell 6.01% to $0.09. The company's market cap stands at $4.0 million. </li>
<li>Kidpik (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) shares declined by 5.69% to $4.31. The company's market cap stands at $8.1 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) stock fell 4.26% to $2.18. The company's market cap stands at $587.2 million. </li>
<li>Cazoo Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CZOO#NYSE">CZOO</a>) stock fell 4.17% to $11.5. The market value of their outstanding shares is at $56.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CURV

CZOO

FFIE

GSUN

NAAS

WKSP

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

U.S. stock futures were mixed this morning, with the Dow futures gaining by around 10 points on Thursday.
Shares of MillerKnoll, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlkn#NASDAQ">MLKN</a>) fell sharply in today&rsquo;s pre-market trading as the company reported downbeat sales for its third quarter and issued weak <a href="https://www.benzinga.com/quote/MLKN/earnings">guidance for the fourth quarter</a>.
MillerKnoll posted quarterly adjusted earnings of 45 cents per share, versus market estimates of 44 cents per share. The company&rsquo;s quarterly sales came in at $872.300 million, missing expectations of $909.500 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
MillerKnoll shares plunged 17.4% to $25.19 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>GCT Semiconductor Holding Inc, (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gcts#NYSE">GCTS</a>) shares tumbled 21.2% to $34.68 in pre-market trading amid volatility following the company&#39;s recently completed business combination with Concord Acquisition Corp III and NYSE debut.</li>
<li>The Chemours Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cc#NYSE">CC</a>) shares fell 10% to $26.00 in pre-market trading after the company reported fourth-quarter results. The company also disclosed material weaknesses and remediation plan.</li>
<li>The E.W. Scripps Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssp#NASDAQ">SSP</a>) shares declined 5.3% to $3.75 in pre-market trading. Fox Factory Holding will replace E.W. Scripps in the S&amp;P SmallCap 600, effective prior to the open of trading on April 3.</li>
<li>Better Home &amp; Finance Holding Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/betr#NASDAQ">BETR</a>) shares fell 5% to $0.5169 in pre-market trading after gaining around 5% on Wednesday.</li>
<li>Reddit, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rddt#NYSE">RDDT</a>) shares fell 4.7% to $55.04 in pre-market trading after declining 11% on Wednesday. Ross Gerber, the President and CEO of Gerber Kawasaki Wealth and Investment Management, has raised questions about the advertising model of Reddit.</li>
<li>Rumble Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rum#NASDAQ">RUM</a>) shares declined 4.2% to $8.14 in pre-market trading following downbeat quarterly sales.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/woof#NASDAQ">WOOF</a>) shares fell 3.7% to $2.11 in pre-market trading after surging over 16% on Wednesday.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37975784/investor-optimism-improves-s-p-500-settles-at-new-record"> Investor Optimism Improves; S&amp;P 500 Settles At New Record</a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

MillerKnoll Posts Weak Sales, Joins Chemours, Rumble And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Wells Fargo analyst Zachary Fadem maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and lowers the price target from $3 to $2.

Wells Fargo Maintains Equal-Weight on Petco Health and Wellness, Lowers Price Target to $2

RBC Capital analyst Steven Shemesh maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and lowers the price target from $3.5 to $2.7.

RBC Capital Maintains Outperform on Petco Health and Wellness, Lowers Price Target to $2.7

4 analysts have shared their evaluations of Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $3.4, a high estimate of $5.00, and a low estimate of $2.50. Experiencing a 15.0% decline, the current average is now lower than the previous average price target of $4.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1710507608_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Petco Health and Wellness. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Oliver Wintermantel</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$3.00</td>
<td>$4.00</td>
</tr>
<tr>
<td>Justin Kleber</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Anna Andreeva</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Hold</td>
<td>$3.11</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Petco Health and Wellness. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Petco Health and Wellness compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Petco Health and Wellness's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Petco Health and Wellness's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WOOF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Petco Health and Wellness analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Petco Health and Wellness Better</h2>
Petco Health and Wellness Co Inc offer pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
<h3>Financial Milestones: Petco Health and Wellness's Journey</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Petco Health and Wellness's revenue growth over a period of 3 months has faced challenges. As of 31 October, 2023, the company experienced a revenue decline of approximately -0.47%. This indicates a decrease in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Petco Health and Wellness's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -83.07%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Petco Health and Wellness's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -68.81%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Petco Health and Wellness's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -20.53%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Petco Health and Wellness's debt-to-equity ratio surpasses industry norms, standing at 2.54. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 4 Analyst Recommendations For Petco Health and Wellness

Evercore ISI Group analyst Oliver Wintermantel maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a In-Line and lowers the price target from $4 to $3.

Evercore ISI Group Maintains In-Line on Petco Health and Wellness, Lowers Price Target to $3

Petco Health And Wellness shares are trading lower on continued weakness following the company's recent Q1 financial results.

Shares of Limbach Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmb#NASDAQ">LMB</a>) fell sharply during Thursday&rsquo;s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.
Limbach said it sees FY24 revenue of $510 million to $530 million, versus market estimates of $541.1 million.
Limbach shares dipped 14.7% to $42.42 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Aptorum Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apm#NASDAQ">APM</a>) shares climbed 91% to $8.27.</li>
<li>Presto Automation Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prst#NASDAQ">PRST</a>) shares jumped 65.2% to $0.3715 after jumping 15% on Wednesday.</li>
<li>Cheer Holding, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chr#NASDAQ">CHR</a>) surged 43.3% to $3.77 following full year 2023 financial results.</li>
<li>WiMi Hologram Cloud Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wimi#NASDAQ">WIMI</a>) shares gained 36.9% to $1.5060.</li>
<li>Turtle Beach Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hear#NASDAQ">HEAR</a>) gained 29.2% to $14.25 after the company announced the acquisition of PDP and its intention to launch a modified &quot;Dutch Auction&quot; Tender Offer. The company also reported fourth-quarter financial results.</li>
<li>VAALCO Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/egy#NYSE">EGY</a>) rose 22% to $5.45 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Build-A-Bear Workshop, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbw#NYSE">BBW</a>) gained 15.7% to $29.20 after the company reported better-than-expected fourth-quarter EPS but missed on revenue. Additionally, the company guided FY24 revenue growth on a low-to-mid-single-digit percentage basis.</li>
<li>Unicycive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uncy#NASDAQ">UNCY</a>) gained 15% to $1.5980. The company announced a $50 million private placement.</li>
<li>DICK&#39;S Sporting Goods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dks#NYSE">DKS</a>) rose 14.8% to $215.70 after the company reported strong fourth-quarter results and issued guidance above consensus estimates.</li>
<li>Lithium Americas Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lac#NYSE">LAC</a>) surged 14.6% to $6.57 after the company announced that it received a conditional commitment from the U.S. Department of Energy for a $2.26 billion loan under the Advanced Technology Vehicles Manufacturing Loan Program for financing the construction of the processing facilities at Thacker Pass in Nevada.</li>
<li>Auddia Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auud#NASDAQ">AUUD</a>) shares gained 11.5% to $3.07 after falling 6% on Wednesday.</li>
<li>Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) gained 11.5% to $126.53 after the company announced a patent litigation settlement with NXP Semiconductors.</li>
<li>ShiftPixy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) gained 9.2% to $3.5501 after gaining over 3% on Wednesday.</li>
<li>CCSC Technology International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cctg#NASDAQ">CCTG</a>) rose 8.7% to $3.6401 after gaining 14% on Wednesday.</li>
<li>Eventbrite, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eb#NYSE">EB</a>) surged 8.7% to $5.55. Eventbrite announced a $100 million share repurchase program.</li>
<li>Perfect Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/perf#NYSE">PERF</a>) gained 8.6% to $2.8550.</li>
<li>Robinhood Markets, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hood#NASDAQ">HOOD</a>) rose 6.3% to $18.24 after the company reported February trading metrics.</li>
<li>Spero Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spro#NASDAQ">SPRO</a>) climbed 5.1% to $1.7450 following better-than-expected fourth-quarter financial results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Spruce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprb#NASDAQ">SPRB</a>) shares dipped 78.5% to $1.1150 after the company reported FY23 financial results. Also, the company announced that the CAHmedlia-203 study of Tildacerfont in adult classic congenital adrenal hyperplasia with severe hyperandrogenemia did not meet its primary efficacy endpoint.</li>
<li>Better Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bttx#NASDAQ">BTTX</a>) tumbled 78% to $0.0452. Better Therapeutics announced it will seek strategic alternatives and will be delisted from the Nasdaq.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) fell 49% to $0.1644 following a Wall Street Journal report suggesting the company is preparing for a possible bankruptcy filing.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) dipped 33.7% to $0.4182.</li>
<li>Immuneering Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrx#NASDAQ">IMRX</a>) fell 31.6% to $4.02 after the company announced topline results from Phase 1 portion of its Phase 1/2a clinical trial of IMM-1-104 in RAS-mutant solid tumors.</li>
<li>RCM Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcmt#NASDAQ">RCMT</a>) dipped 27.9% to $20.74 following weak quarterly sales.</li>
<li>Katapult Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kplt#NASDAQ">KPLT</a>) declined 27% to $13.44 following fourth-quarter results.</li>
<li>Hello Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/momo#NASDAQ">MOMO</a>) fell 24.1% to $5.82 after the company reported fourth-quarter financial results and issued first-quarter revenue guidance.</li>
<li>First Wave BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fwbi#NASDAQ">FWBI</a>) dipped 23.8% to $4.9750. First Wave BioPharma announcec completion of business combination with ImmunogenX.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) declined 22.5% to $12.02 after the company commenced an underwritten offering of 6.5 million shares.</li>
<li>RumbleON, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rmbl#NASDAQ">RMBL</a>) fell 21.8% to $5.55 following weak quarterly sales.</li>
<li>Pangaea Logistics Solutions, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panl#NASDAQ">PANL</a>) dipped 20% to $6.62 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Regulus Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgls#NASDAQ">RGLS</a>) tumbled 16.9% to $2.0188.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/woof#NASDAQ">WOOF</a>) fell 16.4% to $2.1050. Baird analyst Justin Kleber maintained Petco Health and Wellness with a Neutral and lowered the price target from $3 to $2.5.</li>
<li>G-III Apparel Group, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/giii#NASDAQ">GIII</a>) fell 16.3% to $25.37 following mixed fourth-quarter financial results. The company also issued lower-than-expected revenue and EPS guidance for FY25.</li>
<li>NextNav Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nn#NASDAQ">NN</a>) fell 15% to $4.7640 after posting a quarterly loss.</li>
<li>SentinelOne, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/s#NYSE">S</a>) dipped 14.9% to $23.78 after the company reported fourth-quarter financial results and issued guidance.</li>
<li>Erayak Power Solution Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/raya#NASDAQ">RAYA</a>) fell 14.5% to $0.8025 after surging 31% on Wednesday.</li>
<li>Global Gas Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgas#NASDAQ">HGAS</a>) shares fell 13.3% to $2.15 after surging 16% on Wednesday.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) declined 12.8% to $4.0540.</li>
<li>Highest Performances Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/puyi#NASDAQ">PUYI</a>) dipped 12.6% to $7.47.</li>
<li>Under Armour, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uaa#NYSE">UAA</a>) dipped 12.6% to $7.07 amid volatility following a CEO transition. Additionally, Williams Trading downgraded the stock from Buy to Hold and announced an $8 price target.</li>
<li>Vroom, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrm#NASDAQ">VRM</a>) shares tumbled 11.2% to $15.53 as the company reported a loss of $80.51 per share for the fourth quarter. The company&rsquo;s quarterly sales came in at $235.92 million which beat the analyst consensus estimate of $232 million.</li>
<li>Futu Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/futu#NASDAQ">FUTU</a>) shares fell 9.5% to $59.17 following fourth-quarter results.</li>
<li>Madrigal Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdgl#NASDAQ">MDGL</a>) fell 9.1% to $248.09.</li>
<li>Qilian International Holding Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qli#NASDAQ">QLI</a>) shares tumbled 8.8% to $0.5921 after surging 18% on Wednesday.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) fell 8.3% to $35.56.</li>
<li>UiPath Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/path#NYSE">PATH</a>) fell 6.8% to $22.72 after the company reported fourth-quarter financial results.</li>
<li>Anheuser-Busch InBev SA/NV (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bud#NYSE">BUD</a>) shares fell 4.7% to $61.51 after Altria announced its intent to sell a portion of its investment in the company.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37701714/ethereum-falls-below-4-000-following-ppi-data-bittensor-apecoin-among-top-losers"> Ethereum Falls Below $4,000 Following PPI Data; Bittensor, ApeCoin Among Top Losers </a>

Intraday Update

AFRM

AUUD

BTTX

CCTG

FUTU

FWBI

GIII

HEAR

HGAS

HOOD

IMRX

KPLT

MDGL

MOMO

NOVA

PANL

PATH

PERF

PIXY

PRST

PUYI

RAYA

RCMT

RGLS

RMBL

SPRB

SPRO

TCON

UNCY

WIMI

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Baird analyst Justin Kleber maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Neutral and lowers the price target from $3 to $2.5.

Baird Maintains Neutral on Petco Health and Wellness, Lowers Price Target to $2.5

Needham analyst Anna Andreeva maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Buy and maintains $5 price target.

Needham Maintains Buy on Petco Health and Wellness, Maintains $5 Price Target

Petco Health And Wellness Co Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported fourth-quarter FY23 sales growth of 6.1% year-on-year to $1.67 billion,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/03/n37650406/petco-health-wellness-company-inc-reports-fourth-quarter-and-full-year-2023-earnings" rel="noreferrer noopener">beating the analyst consensus of $1.62 billion</a>.
Comparable sales declined 0.9% versus last year and increased 4.4% on a two-year basis.
Gross profit decreased 3% Y/Y to $606.348 million, with a profit margin of 36.2%. Adjusted EPS of $0.02 <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">matched the analyst consensus.</a>
Operating income for the quarter plunged 99.7% to $166,000. Adjusted EBITDA decreased 33.3% Y/Y to $105.3 million.
Petco held $125.4 million in cash and equivalents as of February 3, 2024. Cash provided by operating activities for the quarter totaled $47 million, with a free cash flow of $(2.0) million.
Outlook: Petco expects first quarter 2024 net sales of ~$1.5 billion versus the Street view of $1.56 billion.
The company sees first quarter adjusted EPS of $(0.06) against an estimate of $(0.01). For fiscal 2024, the company expects a capital expenditure of ~$140 million.
Price Action: WOOF shares are trading lower by 5.86% at $2.41 on the last check Wednesday.
Photo via Pixabay

Guidance

General

Why Petco Health And Wellness Shares Are Falling Today

PLAB, SMTC and WOOF are among after hour movers

Petco sheds 9% after double downgrade from BofA

Petco Health And Wellness Q4: Staying Away Because Of All The Uncertainties

Wall Street Lunch: Tesla's Q1 Deliveries Disappoint

Petco Health And Wellness Company Inc (WOOF) has disclosed a new risk, in the Accounting & Financial Operations category. Petco Health and Wellness...

Petco's Financial Health in Jeopardy: Impairment Charges Point to Potential Troubles Ahead

GRIN, WOOF and MRNS are among after hour movers

The latest update is out from Petco Health and Wellness Company (WOOF). Petco Health and Wellness Company has announced the Board of Directors' dec...

Petco Announces Chief Customer Officer's Termination

Petco Health and Wellness terminates chief customer officer Darren MacDonald

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Generally speaking, <a href="https://investorplace.com/stock-types/undervalued-stocks/">undervalued stocks</a> under $5 should be avoided. Yeah, I know that&rsquo;s not exactly the catchiest tagline to offer. Let me explain.



If you believe that the market represents the culmination at that moment of all available public information, then nothing really is under or overvalued. Securities are priced exactly where they should be given the information at hand. However, the thesis behind bargain ideas &ndash; particularly undervalued stocks under $5 &ndash; is that it&rsquo;s practically impossible to know all things, all the time.



For example, Jim Cramer knows a lot about publicly traded enterprises but he doesn&rsquo;t know them all. An army of Jim Cramers would not be able to cover every opportunity adequately. So, some promising ideas will be left on the sidelines, just waiting for an opportunity. That&rsquo;s the allure (and the risk) behind these undervalued stocks under $5.



<h2>FuboTV (FUBO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/fubo_fubotv_1600-300x169.png" alt="FuboTV (FUBO) logo on iPhone display"><div>Source: Burdun Iliya / Shutterstock.com</div></div>A live TV streaming platform sports, news and entertainment content, FuboTV (NYSE:<a href="https://investorplace.com/stock-quotes/fubo-stock-quote/">FUBO</a>) represents an intriguing idea for undervalued stocks under $5. Currently, shares trade hands for <a href="https://www.gurufocus.com/stock/FUBO/summary?search=fubo">only 0.32X trailing-year revenue</a>. That&rsquo;s well off the sector&rsquo;s median value of 1.25X. On that basis, FUBO stock seems like a steal. However, viability concerns have dogged the investment.



Since the start of the year, shares have lost 52% of equity value. Over the past five years, FUBO went into the red to the tune of over 80%. That&rsquo;s an ugly print. Not surprisingly, analysts rate shares a <a href="https://www.tipranks.com/stocks/fubo/forecast">consensus hold</a>, with one of the ratings coming in as a sell. However ,the average price target stands at $2.88, implying almost 91% upside potential.



Here&rsquo;s the deal. While Fubo struggles for credibility, in the past fiscal year, the average quarterly surprise landed at 22.8%. What&rsquo;s more, experts anticipate that the current fiscal year&rsquo;s top line will jump to $1.56 billion. That would be up 14% from last year&rsquo;s tally of $1.37 billion. Thus, the lowly sales multiple seems very attractive.



<h2>Petco (WOOF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/12/woof-stock-1-300x169.jpg" alt="The front of a Petco (WOOF) store in Los Angeles, California."><div>Source: Walter Cicchetti / Shutterstock.com</div></div>Operating as a health and wellness company, Petco (NASDAQ:<a href="https://investorplace.com/stock-quotes/woof-stock-quote/">WOOF</a>) focuses on enhancing the lives of pets, pet parents and its company partners. It covers the U.S., Mexico and Puerto Rico. Petco provides a variety of services, including veterinary care and grooming. However, WOOF stock has struggled, losing more than 41% of market value since the beginning of January.



At the same time, WOOF could be a risky contrarian opportunity for gamblers. Right now, shares trade at a subterranean <a href="https://www.gurufocus.com/stock/WOOF/summary?search=woof">sales multiple of 0.08X</a>. Right off the bat, that sounds incredibly treacherous. There&rsquo;s value and then there are value traps. Still, analysts peg WOOF stock as a consensus moderate buy with a $3.30 price target. That implies over 78% upside potential.



To be sure, Petco&rsquo;s performance in the past four quarters have been all over the map. Sometimes it hits big, other times, it misses badly. And projections for the current fiscal year (2025) aren&rsquo;t great, with revenue probably coming in at $6.13 billion. That&rsquo;s 2% lower than last year&rsquo;s haul of $6.26 billion.



Still, here&rsquo;s the bullish thesis: the <a href="https://www.americanpetproducts.org/research-insights/industry-trends-and-stats#:~:text=Actual%20Sales%20within%20the%20U.S.,our%20pets%20in%20the%20U.S.">U.S. pet market is booming</a>. And it&rsquo;s possible that WOOF could ride coattails. If so, it could rank among the undervalued stocks under $5.



<h2>Broadwind (BWEN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1932365063-300x169.png" alt="Environmental protection, renewable, sustainable energy sources. Plant growing in the bulb concept. renewable energy stocks to buy"><div>Source: Proxima Studio / Shutterstock.com</div></div>Operating under the specialty industrial machinery subcategory, Broadwind (NASDAQ:<a href="https://investorplace.com/stock-quotes/bwen-stock-quote/">BWEN</a>) manufactures and sells structures, equipment, and components for clean tech and other specialized applications primarily in the U.S. It operates through three segments: Heavy Fabrications, Gearing and Industrial Solutions. Notably, it offers significant relevancies for the manufacturing of wind turbines.



Despite the pertinence to the burgeoning renewable energy space, BWEN has struggled in the market. Since the start of the year, it&rsquo;s down almost 13%. Over the past 52 weeks, the security slipped roughly 36%. Nevertheless, the good news is that shares now trade for only 0.25X trailing-year revenue.



In fairness, the discount in the sales multiple stems from analysts reduced expectations for the current fiscal year. They&rsquo;re looking at sales of $150.26 million on average. Even at the high end of $165.3 million, it&rsquo;s off from last year&rsquo;s tally of $203.48 million.



However, a recovery could take place in fiscal 2025, with the high-side revenue reaching over $225 million. With shares appearing to stabilize since November last year, BWEN could be one of the undervalued stocks under $5 to consider.



<a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a>



On Penny Stocks and Low-Volume Stocks:&nbsp;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&nbsp;<a href="http://investorplace.com/">InvestorPlace.com</a>&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&nbsp;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">How to Profit Without Getting Scammed</a>



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/the-3-most-undervalued-stocks-under-5-to-buy-in-april-2024/">The 3 Most Undervalued Stocks Under $5 to Buy in April 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The 3 Most Undervalued Stocks Under $5 to Buy in April 2024

U.S. election: Target and these retailers could see an outsized benefit in a GOP sweep scenario

AMZN

ANAB

ANGO

APLS

ARBK

ARHS

BCAB

BWEN

CADL

EIGR

FIVE

FUBO

GRIN

JRVR

LOVE

MRNS

OLLI

PLAB

SGMT

SMTC

ZNTL

Press Releases

Petco Helps Pet Parents Make Every Moment Merry with One-Stop Holiday Shop

Petco Health + Wellness Company, Inc. Reports Third Quarter Earnings

Opinion

Thinking about buying stock in RedHill Biopharma, Mynaric, Energy Transfer LP, Seelos Therapeutics, or Petco Health and Wellness?

Petco and Nationwide® launch co-branded pet insurance product on petco.com

Petco Health and Wellness Company, Inc. to Host Fourth Quarter 2023 Earnings Conference Call on March 13, 2024

Petco Names Holly May as Chief Human Resources Officer

Petco to Participate in the UBS Global Consumer and Retail Conference

Petco Announces CEO Transition

Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2023 Earnings

PSA: As Pandemic Pets Enter New Life Stages, Petco Shares Tips for Supporting Pet Health and Wellness